The potential value of lactoferrin in the treatment of anemia and anemia of inflammation (AI) in mixed groups of pregnant and non-pregnant women (minor β-thalassemia, hereditary thrombophilia, AI, mixed group) was investigated by Lepanto et al. in an interventional study [47]. This evidence concerns the gene LTF and thrombophilia.